Results 181 to 190 of about 6,658 (202)

Rucaparib particles and uses thereof

2023
SITTENAUER JACOB, ABARCA ARANZA BARREDA, CLARK SHELBY, FARTHING JOSEPH, WILLIAMS MARK, DIZEREGA GERE S, BALTEZOR MICHAEL   +6 more
openaire   +2 more sources

Breast Cancer Resistance Protein (BCRP/ABCG2) and P-Glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)

Pharmaceutical Research, 2015
Rolf W Sparidans, Alfred H Schinkel, Jos Beijnen   +2 more
exaly  

SOLID STATE FORMS OF RUCAPARIB AND OF RUCAPARIB SALTS

2018
SAMEC DIJANA SKALEC, DOGAN JASNA, BILJAN TOMISLAV, SKUGOR MAJA MATANOVIC, MIHOVILOVIC MORIS, MUNDORFER TINA, JANTON NIKOLINA, TUKSAR MIHAELA, PIPERCIC SARA MORASI, BAUS NEA   +9 more
openaire   +4 more sources

Rucaparib

Reactions Weekly
openaire   +1 more source

Rucaparib: The Past, Present, and Future of a Newly Approved PARP Inhibitor for Ovarian Cancer

OncoTargets and Therapy, 2017
Lauren Dockery, Kathleen N. Moore
exaly  

The Poly (ADP-Ribose) Polymerase Inhibitor Rucaparib Suppresses Proliferation and Serves as an Effective Radiosensitizer in Cervical Cancer

Investigational New Drugs, 2019
Jin Jin Yu, Haifeng Qiu, Leyuan Zhou
exaly  

Crystalline of camphorsulfonic acid salt of rucaparib and method of preparing of tricyclic compounds, rucaparib and crystalline of camphorsulfonic acid salt of rucaparib

2021
YANG WEN-CHIEH, LEE MEI-JING, LEE HSUEH-CHEN, LI LUNG-HSIANG   +3 more
openaire   +1 more source

Summary of opinion: Rubraca,rucaparib

Case Medical Research, 2018
openaire   +2 more sources

A Pan-Tumor Review of the Role of Poly(Adenosine Diphosphate Ribose) Polymerase Inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer K Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly  

Rucaparib: An Emerging Parp Inhibitor for Treatment of Recurrent Ovarian Cancer

Cancer Treatment Reviews, 2018
Erlisa Bardhi, Claudia Marchetti, Ludovico Muzii   +2 more
exaly